JP2010534698A5 - - Google Patents

Download PDF

Info

Publication number
JP2010534698A5
JP2010534698A5 JP2010518562A JP2010518562A JP2010534698A5 JP 2010534698 A5 JP2010534698 A5 JP 2010534698A5 JP 2010518562 A JP2010518562 A JP 2010518562A JP 2010518562 A JP2010518562 A JP 2010518562A JP 2010534698 A5 JP2010534698 A5 JP 2010534698A5
Authority
JP
Japan
Prior art keywords
dextrose composition
directly compressible
dextrose
tablet
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010518562A
Other languages
English (en)
Japanese (ja)
Other versions
JP5623275B2 (ja
JP2010534698A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/006283 external-priority patent/WO2009015880A1/en
Publication of JP2010534698A publication Critical patent/JP2010534698A/ja
Publication of JP2010534698A5 publication Critical patent/JP2010534698A5/ja
Application granted granted Critical
Publication of JP5623275B2 publication Critical patent/JP5623275B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010518562A 2007-07-31 2008-07-30 直接打錠可能なデキストロース Active JP5623275B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07015044 2007-07-31
EP07015044.6 2007-07-31
PCT/EP2008/006283 WO2009015880A1 (en) 2007-07-31 2008-07-30 Direct compressible dextrose

Publications (3)

Publication Number Publication Date
JP2010534698A JP2010534698A (ja) 2010-11-11
JP2010534698A5 true JP2010534698A5 (cg-RX-API-DMAC7.html) 2011-08-18
JP5623275B2 JP5623275B2 (ja) 2014-11-12

Family

ID=39227032

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010518562A Active JP5623275B2 (ja) 2007-07-31 2008-07-30 直接打錠可能なデキストロース

Country Status (9)

Country Link
US (2) US20100273873A1 (cg-RX-API-DMAC7.html)
EP (1) EP2175740B1 (cg-RX-API-DMAC7.html)
JP (1) JP5623275B2 (cg-RX-API-DMAC7.html)
CN (1) CN101772304B (cg-RX-API-DMAC7.html)
BR (1) BRPI0815376A2 (cg-RX-API-DMAC7.html)
CA (1) CA2694516A1 (cg-RX-API-DMAC7.html)
ES (1) ES2686081T3 (cg-RX-API-DMAC7.html)
RU (1) RU2471356C2 (cg-RX-API-DMAC7.html)
WO (1) WO2009015880A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX337827B (es) 2011-04-06 2016-03-22 Dow Global Technologies Llc Novedosos derivados polisacaridos y formas de administracion.
KR101923723B1 (ko) 2012-09-17 2018-11-29 한국전자통신연구원 사용자 간 상호작용이 가능한 메타버스 공간을 제공하기 위한 메타버스 클라이언트 단말 및 방법
PL3116325T3 (pl) * 2014-03-11 2021-08-02 Mars, Incorporated Kompozycja czekolady odpornej na wysokie temperatury i sposób jej sporządzania
KR102501024B1 (ko) 2014-07-21 2023-02-20 로께뜨프레르 직접 압축에 의한 타정을 위한 당 조성물
LT3256107T (lt) * 2015-02-09 2020-09-25 Rivopharm Sa Racekadotrilo farmacinė vaisto forma
CN105148280A (zh) * 2015-07-07 2015-12-16 深圳国源国药有限公司 一种创新药用辅料可压性蔗糖及其制备方法
CN108553645A (zh) * 2018-03-27 2018-09-21 天津信诚康达药业有限公司 一种创新型辅料蔗糖及其制备方法
WO2020252284A1 (en) * 2019-06-13 2020-12-17 Imbucanna, Inc Compressible cannabinoid pharmaceutical composition
WO2020254940A1 (en) * 2019-06-15 2020-12-24 Shrinivasan Shesha Iyengar Glucose sustained release compositions and it's process
DK4146164T3 (da) * 2020-05-08 2025-05-26 Fertin Pharma As Flowpack til oral afgivelse af aktive ingredienser
US20230123099A1 (en) * 2021-10-15 2023-04-20 Fertin Pharma A/S Dextrose tablets with improved mouthfeel

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3619292A (en) * 1968-07-15 1971-11-09 Penick & Ford Ltd Tablets and method of forming
US4072535A (en) * 1970-12-28 1978-02-07 A. E. Staley Manufacturing Company Precompacted-starch binder-disintegrant-filler material for direct compression tablets and dry dosage capsules
US4684534A (en) * 1985-02-19 1987-08-04 Dynagram Corporation Of America Quick-liquifying, chewable tablet
DE19615422A1 (de) * 1996-04-19 1997-11-20 Boehringer Ingelheim Kg Zweikammer-Kartusche für treibgasfreie Dosieraerosole
GB9613470D0 (en) * 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
CA2260038A1 (en) * 1996-07-12 1998-01-22 Daiichi Pharmaceutical Co., Ltd. Quickly disintegratable compression-molded materials and process for producing the same
FR2787811B1 (fr) * 1998-12-24 2001-03-02 Roquette Freres Dextrose pulverulent et son procede de preparation
US6527868B2 (en) * 1999-12-15 2003-03-04 Roquette Freres Dextrose in powder form and a process for the preparation thereof
FR2802551B1 (fr) * 1999-12-17 2006-08-04 Roquette Freres Dextrose hydrate pulverulent et son procede de preparation
RU2262922C2 (ru) * 2001-05-15 2005-10-27 Уорнер-Ламберт Компани Ллс Способ прессования для получения лекарственной формы фенитоина натрия
BR0215193A (pt) * 2001-12-21 2004-11-16 Pfizer Prod Inc Formulações de azitromicina diretamente compressìveis
KR100967782B1 (ko) * 2002-02-14 2010-07-05 글락소 그룹 리미티드 N-((1-N-부틸-4-피페리디닐)메틸)-3,4-디하이드로-2H-(1,3)옥사지노(3,2-a)인돌-10-카복스아미드 또는 그의 염을포함하는 제약 조성물, 및 건식 과립화를 포함하는 그의제조 방법
US20070178150A1 (en) * 2003-07-10 2007-08-02 Prasad Adusumilli Pharmaceutical compositions
BRPI0413394A8 (pt) * 2003-08-26 2016-03-08 Shire Holdings Ag Formulação de lantânio mastigável em tablete, formulação farmacêutica em tablete ou em pó, método para tratar hiperfosfatemia, uso de uma quantidade terapeuticamente efetiva de uma formulação de um composto de lantânio, processo para preparar uma formulação em tablete de um composto de lantânio
TWI354569B (en) * 2004-05-28 2011-12-21 Bristol Myers Squibb Co Coated tablet formulation and method

Similar Documents

Publication Publication Date Title
JP2010534698A5 (cg-RX-API-DMAC7.html)
RU2010107185A (ru) Декстроза для прямого прессования
Inghelbrecht et al. Roller compaction and tableting of microcrystalline cellulose/drug mixtures
Martins et al. Effect of Grewia gum on the mechanical properties of Paracetamol tablet formulations
EP2777696B1 (en) Preparation of stable pharmaceutical dosage forms
RU2011112805A (ru) Таблетирование эритрита
KR20170043597A (ko) 루카파립의 고 용량 강도 정제
RU2019110089A (ru) Усовершенствованная машина и способ упаковки в растягивающуюся пленку изделий, подаваемых блоками или по отдельности
Tanimura et al. Spray-dried composite particles of erythritol and porous silica for orally disintegrating tablets prepared by direct tableting
JP5944378B2 (ja) アカルボースを含む口腔内崩壊錠
CN102665764A (zh) 可用作可再压实药物赋形剂的微晶纤维素和碳酸钙组合物
Gowthamarajan et al. Preliminary study of Anacardium occidentale gum as binder in formulation of paracetamol tablets
RU2008130074A (ru) Твердый препарат
EP1994926B9 (en) Valsartan formulations
Emeje et al. Compaction characteristics of ethylcellulose in the presence of some channeling agents
Ghule et al. Evaluation of Binding Properties of Evaluation of Binding Properties of Eulophia campestris Wall. Mucilage all. Mucilage
WO2008020990A1 (en) New direct compressible excipient blend
Patil et al. Natural binders in tablet formulation
Khandai et al. Critical analysis of algino-carbopol multiparticulate system for the improvement of flowability, compressibility and tableting properties of a poor flow drug
ES2707275T3 (es) Composiciones con liberación rápida de fármaco
Gbenga et al. New Matrix Tablet from Okra gum: Effects of Method of preparation and gum concentration on Tablet Properties
JP5755382B2 (ja) 口腔内崩壊錠
IL200447A0 (en) Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby
CN106109428B (zh) 瑞格列奈二甲双胍的制剂工艺
JP2007161706A (ja) 安中散含有錠剤